Investors
Committed to increase our long-term value
Nycomed is a privately owned pharmaceutical company that has expanded rapidly in recent years in terms of global presence, number of employees and new products. Our investors have a strong sense of financial engagement and a unique entrepreneurial spirit.
Ownership
Nycomed is owned by a consortium of investors with a long-term perspective.
Performance Indicators
In 2009, Nycomed had a net turnover of € 3.2 billion and an adjusted EBITDA of € 1.1 billion.
Financial Reports
Detailed analysis of our business results can be found in our Annual Report and Interim Reports.
Financial Calendar
We provide updates about our business performance each quarter.